We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+16.51%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
-$485M
(-20%)
Cap. Flow
-$562M
Cap. Flow
% of AUM
-29.17%
Top 10 Holdings %
Top 10 Hldgs %
5.51%
Holding
3,496
New
1,220
Increased
551
Reduced
717
Closed
1,006
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$10.4M |
| 2 |
Cisco
CSCO
|
+$7.97M |
| 3 |
American Tower
AMT
|
+$7.79M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$7.33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$16.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$15.1M |
| 3 |
Amazon
AMZN
|
+$13.7M |
| 4 |
Philip Morris
PM
|
+$13.5M |
| 5 |
Amphenol
APH
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14% |
| 3 | Healthcare | 12.51% |
| 4 | Consumer Discretionary | 11.31% |
| 5 | Industrials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Vera Bradley
VRA
$104M
| $36.8K | ﹤0.01% |
18,302
-38,581
| -68% | -$81.8K |
|
2227
Trio Petroleum
TPET
$11.8M
| $36.7K | ﹤0.01% |
34,988
+24,469
| +233% | +$28.4K |
|
|
UXIN
2228
Uxin Ltd
UXIN
$315M
| $36.5K | ﹤0.01% |
+10,559
| New | +$40.4K |
|
2229
Incannex Healthcare
IXHL
$35.4M
| $36.3K | ﹤0.01% |
+2,609
| New | +$42.4K |
|
2230
Metagenomi Therapeutics
MGX
$45.6M
| $36.1K | ﹤0.01% |
+15,216
| New | +$30.9K |
|
2231
Freightos
CRGO
$64.6M
| $35.8K | ﹤0.01% |
+10,858
| New | +$32.5K |
|
|
BOLD
2232
Boundless Bio
BOLD
$55.5M
| $35.8K | ﹤0.01% |
29,081
-10,983
| -27% | -$12.7K |
|
2233
Clarus
CLAR
$128M
| $35.7K | ﹤0.01% |
+10,199
| New | +$36.9K |
|
|
CNTB
2234
Connect Biopharma Holdings
CNTB
$131M
| $35.1K | ﹤0.01% |
23,724
-5,138
| -18% | -$9.1K |
|
2235
Nkarta
NKTX
$159M
| $34.9K | ﹤0.01% |
+16,874
| New | +$34.6K |
|
|
VXRT
2236
DELISTED
Vaxart
VXRT
| $34.4K | ﹤0.01% |
94,258
+70,364
| +294% | +$28.9K |
|
2237
PodcastOne
PODC
$115M
| $34.3K | ﹤0.01% |
+20,437
| New | +$36.7K |
|
|
IMRN
2238
Immuron
IMRN
$8.84M
| $34.3K | ﹤0.01% |
+17,968
| New | +$32.1K |
|
|
SAGT
2239
Sagtec Global
SAGT
$14.4M
| $34.1K | ﹤0.01% |
+16,635
| New | +$34.7K |
|
|
LVTX
2240
DELISTED
LAVA Therapeutics
LVTX
| $33.9K | ﹤0.01% |
+21,727
| New | +$32.5K |
|
|
MYSE
2241
Myseum.AI Inc
MYSE
$12.6M
| $33.9K | ﹤0.01% |
14,979
-870
| -5% | -$1.99K |
|
2242
Dawson Geophysical
DWSN
$137M
| $33.8K | ﹤0.01% |
+19,177
| New | +$29.2K |
|
2243
Usio Inc
USIO
$53.8M
| $33.6K | ﹤0.01% |
23,638
-5,583
| -19% | -$8.81K |
|
2244
Wrap Technologies
WRAP
$96.4M
| $33.5K | ﹤0.01% |
15,418
-4,848
| -24% | -$7.81K |
|
2245
Senseonics Holdings Inc
SENS
$256M
| $33.4K | ﹤0.01% |
+3,831
| New | +$37K |
|
|
APUS
2246
Apimeds Pharmaceuticals US
APUS
$12.1M
| $33.3K | ﹤0.01% |
+1,874
| New | +$34.7K |
|
2247
Eledon Pharmaceuticals
ELDN
$262M
| $33.3K | ﹤0.01% |
+12,848
| New | +$37.6K |
|
2248
Cumberland Pharmaceuticals
CPIX
$102M
| $33K | ﹤0.01% |
10,591
+311
| +3% | +$1.03K |
|
2249
Beamr Imaging
BMR
$18.9M
| $32.3K | ﹤0.01% |
+10,544
| New | +$32.2K |
|
2250
TScan Therapeutics
TCRX
$50.6M
| $32.1K | ﹤0.01% |
+17,626
| New | +$31.2K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2025 Portfolio in Review
As of Q3 2025, XTX Topco held 3,496 positions worth $1.93B, down 20% from $2.41B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco withdrew a net $562M in Q3 2025, closing 1,006 positions and reducing 717 holdings. Its most notable exit was T-Mobile US, an estimated $9.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, XTX Topco opened a new position in Johnson & Johnson worth $11.3M.
- XTX Topco's largest Q3 2025 buy was Johnson & Johnson: 60,929 shares worth $11.3M.
- XTX Topco added most to Invesco QQQ Trust in Q3 2025, an estimated $7.33M increase.
- XTX Topco's biggest Q3 2025 reduction was Oracle, cutting an estimated $16.2M.
- XTX Topco fully exited T-Mobile US in Q3 2025, selling an estimated $9.81M.
- XTX Topco's ten largest holdings make up 5.5% of its $1.93B portfolio in Q3 2025.
- XTX Topco opened 1,220 new positions and closed 1,006 in Q3 2025.
- XTX Topco's portfolio value fell 20% quarter-over-quarter to $1.93B.
Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.